【市場調査レポート】インフルエンザ予防接種のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Injection Flu Shot Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。インフルエンザ予防接種のグローバル市場インサイト・予測（～2028年） / Global Injection Flu Shot Market Insights, Forecast to 2028 / QY2207E10385資料のイメージです。

• レポートコード：QY2207E10385
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のインフルエンザ予防接種の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインフルエンザ予防接種の世界市場のxxx％を占める「三価インフルエンザワクチン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「6ヶ月～3年」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のインフルエンザ予防接種の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのインフルエンザ予防接種市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのインフルエンザ予防接種市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

インフルエンザ予防接種のグローバル主要メーカーには、Sanofi、CSL、GSK、Viatris、AstraZeneca、Hualan Bio、Changchun Institute of Biological、Sinovac、Jiangsu GDK、KM Biologicsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

インフルエンザ予防接種市場は、種類と用途によって区分されます。世界のインフルエンザ予防接種市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
三価インフルエンザワクチン、四価インフルエンザワクチン

【用途別セグメント】
6ヶ月～3年、>3年

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- インフルエンザ予防接種製品概要
- 種類別市場（三価インフルエンザワクチン、四価インフルエンザワクチン）
- 用途別市場（6ヶ月～3年、>3年）
- 調査の目的
・エグゼクティブサマリー
- 世界のインフルエンザ予防接種販売量予測2017-2028
- 世界のインフルエンザ予防接種売上予測2017-2028
- インフルエンザ予防接種の地域別販売量
- インフルエンザ予防接種の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別インフルエンザ予防接種販売量
- 主要メーカー別インフルエンザ予防接種売上
- 主要メーカー別インフルエンザ予防接種価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（三価インフルエンザワクチン、四価インフルエンザワクチン）
- インフルエンザ予防接種の種類別販売量
- インフルエンザ予防接種の種類別売上
- インフルエンザ予防接種の種類別価格
・用途別市場規模（6ヶ月～3年、>3年）
- インフルエンザ予防接種の用途別販売量
- インフルエンザ予防接種の用途別売上
- インフルエンザ予防接種の用途別価格
・北米市場
- 北米のインフルエンザ予防接種市場規模（種類別、用途別）
- 主要国別のインフルエンザ予防接種市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのインフルエンザ予防接種市場規模（種類別、用途別）
- 主要国別のインフルエンザ予防接種市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のインフルエンザ予防接種市場規模（種類別、用途別）
- 主要国別のインフルエンザ予防接種市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のインフルエンザ予防接種市場規模（種類別、用途別）
- 主要国別のインフルエンザ予防接種市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのインフルエンザ予防接種市場規模（種類別、用途別）
- 主要国別のインフルエンザ予防接種市場規模（トルコ、サウジアラビア）
・企業情報
Sanofi、CSL、GSK、Viatris、AstraZeneca、Hualan Bio、Changchun Institute of Biological、Sinovac、Jiangsu GDK、KM Biologics
・産業チェーン及び販売チャネル分析
- インフルエンザ予防接種の産業チェーン分析
- インフルエンザ予防接種の原材料
- インフルエンザ予防接種の生産プロセス
- インフルエンザ予防接種の販売及びマーケティング
- インフルエンザ予防接種の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- インフルエンザ予防接種の産業動向
- インフルエンザ予防接種のマーケットドライバー
- インフルエンザ予防接種の課題
- インフルエンザ予防接種の阻害要因
・主な調査結果

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Market Analysis and Insights: Global Injection Flu Shot Market
Due to the COVID-19 pandemic, the global Injection Flu Shot market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Trivalent Influenza Vaccine accounting for % of the Injection Flu Shot global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While 6 Months to 3 Years segment is altered to an % CAGR throughout this forecast period.
China Injection Flu Shot market size is valued at US$ million in 2021, while the US and Europe Injection Flu Shot are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Injection Flu Shot landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Injection Flu Shot include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Jiangsu GDK and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Injection Flu Shot Scope and Segment
Injection Flu Shot market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Injection Flu Shot market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Injection Flu Shot Product Introduction
1.2 Market by Type
1.2.1 Global Injection Flu Shot Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Injection Flu Shot Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Injection Flu Shot Sales Estimates and Forecasts 2017-2028
2.2 Global Injection Flu Shot Revenue Estimates and Forecasts 2017-2028
2.3 Global Injection Flu Shot Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Injection Flu Shot Sales by Region
2.4.1 Global Injection Flu Shot Sales by Region (2017-2022)
2.4.2 Global Sales Injection Flu Shot by Region (2023-2028)
2.5 Global Injection Flu Shot Revenue by Region
2.5.1 Global Injection Flu Shot Revenue by Region (2017-2022)
2.5.2 Global Injection Flu Shot Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Injection Flu Shot Sales by Manufacturers
3.1.1 Global Top Injection Flu Shot Manufacturers by Sales (2017-2022)
3.1.2 Global Injection Flu Shot Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Injection Flu Shot in 2021
3.2 Global Injection Flu Shot Revenue by Manufacturers
3.2.1 Global Injection Flu Shot Revenue by Manufacturers (2017-2022)
3.2.2 Global Injection Flu Shot Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Injection Flu Shot Revenue in 2021
3.3 Global Injection Flu Shot Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Injection Flu Shot Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Injection Flu Shot Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Injection Flu Shot Sales by Type
4.1.1 Global Injection Flu Shot Historical Sales by Type (2017-2022)
4.1.2 Global Injection Flu Shot Forecasted Sales by Type (2023-2028)
4.1.3 Global Injection Flu Shot Sales Market Share by Type (2017-2028)
4.2 Global Injection Flu Shot Revenue by Type
4.2.1 Global Injection Flu Shot Historical Revenue by Type (2017-2022)
4.2.2 Global Injection Flu Shot Forecasted Revenue by Type (2023-2028)
4.2.3 Global Injection Flu Shot Revenue Market Share by Type (2017-2028)
4.3 Global Injection Flu Shot Price by Type
4.3.1 Global Injection Flu Shot Price by Type (2017-2022)
4.3.2 Global Injection Flu Shot Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Injection Flu Shot Sales by Application
5.1.1 Global Injection Flu Shot Historical Sales by Application (2017-2022)
5.1.2 Global Injection Flu Shot Forecasted Sales by Application (2023-2028)
5.1.3 Global Injection Flu Shot Sales Market Share by Application (2017-2028)
5.2 Global Injection Flu Shot Revenue by Application
5.2.1 Global Injection Flu Shot Historical Revenue by Application (2017-2022)
5.2.2 Global Injection Flu Shot Forecasted Revenue by Application (2023-2028)
5.2.3 Global Injection Flu Shot Revenue Market Share by Application (2017-2028)
5.3 Global Injection Flu Shot Price by Application
5.3.1 Global Injection Flu Shot Price by Application (2017-2022)
5.3.2 Global Injection Flu Shot Price Forecast by Application (2023-2028)
6 North America
6.1 North America Injection Flu Shot Market Size by Type
6.1.1 North America Injection Flu Shot Sales by Type (2017-2028)
6.1.2 North America Injection Flu Shot Revenue by Type (2017-2028)
6.2 North America Injection Flu Shot Market Size by Application
6.2.1 North America Injection Flu Shot Sales by Application (2017-2028)
6.2.2 North America Injection Flu Shot Revenue by Application (2017-2028)
6.3 North America Injection Flu Shot Market Size by Country
6.3.1 North America Injection Flu Shot Sales by Country (2017-2028)
6.3.2 North America Injection Flu Shot Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Injection Flu Shot Market Size by Type
7.1.1 Europe Injection Flu Shot Sales by Type (2017-2028)
7.1.2 Europe Injection Flu Shot Revenue by Type (2017-2028)
7.2 Europe Injection Flu Shot Market Size by Application
7.2.1 Europe Injection Flu Shot Sales by Application (2017-2028)
7.2.2 Europe Injection Flu Shot Revenue by Application (2017-2028)
7.3 Europe Injection Flu Shot Market Size by Country
7.3.1 Europe Injection Flu Shot Sales by Country (2017-2028)
7.3.2 Europe Injection Flu Shot Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Injection Flu Shot Market Size by Type
8.1.1 Asia Pacific Injection Flu Shot Sales by Type (2017-2028)
8.1.2 Asia Pacific Injection Flu Shot Revenue by Type (2017-2028)
8.2 Asia Pacific Injection Flu Shot Market Size by Application
8.2.1 Asia Pacific Injection Flu Shot Sales by Application (2017-2028)
8.2.2 Asia Pacific Injection Flu Shot Revenue by Application (2017-2028)
8.3 Asia Pacific Injection Flu Shot Market Size by Region
8.3.1 Asia Pacific Injection Flu Shot Sales by Region (2017-2028)
8.3.2 Asia Pacific Injection Flu Shot Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Injection Flu Shot Market Size by Type
9.1.1 Latin America Injection Flu Shot Sales by Type (2017-2028)
9.1.2 Latin America Injection Flu Shot Revenue by Type (2017-2028)
9.2 Latin America Injection Flu Shot Market Size by Application
9.2.1 Latin America Injection Flu Shot Sales by Application (2017-2028)
9.2.2 Latin America Injection Flu Shot Revenue by Application (2017-2028)
9.3 Latin America Injection Flu Shot Market Size by Country
9.3.1 Latin America Injection Flu Shot Sales by Country (2017-2028)
9.3.2 Latin America Injection Flu Shot Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Injection Flu Shot Market Size by Type
10.1.1 Middle East and Africa Injection Flu Shot Sales by Type (2017-2028)
10.1.2 Middle East and Africa Injection Flu Shot Revenue by Type (2017-2028)
10.2 Middle East and Africa Injection Flu Shot Market Size by Application
10.2.1 Middle East and Africa Injection Flu Shot Sales by Application (2017-2028)
10.2.2 Middle East and Africa Injection Flu Shot Revenue by Application (2017-2028)
10.3 Middle East and Africa Injection Flu Shot Market Size by Country
10.3.1 Middle East and Africa Injection Flu Shot Sales by Country (2017-2028)
10.3.2 Middle East and Africa Injection Flu Shot Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSL Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GSK Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Viatris
11.4.1 Viatris Corporation Information
11.4.2 Viatris Overview
11.4.3 Viatris Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Viatris Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Corporation Information
11.6.2 Hualan Bio Overview
11.6.3 Hualan Bio Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hualan Bio Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hualan Bio Recent Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Corporation Information
11.7.2 Changchun Institute of Biological Overview
11.7.3 Changchun Institute of Biological Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Changchun Institute of Biological Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changchun Institute of Biological Recent Developments
11.8 Sinovac
11.8.1 Sinovac Corporation Information
11.8.2 Sinovac Overview
11.8.3 Sinovac Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sinovac Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sinovac Recent Developments
11.9 Jiangsu GDK
11.9.1 Jiangsu GDK Corporation Information
11.9.2 Jiangsu GDK Overview
11.9.3 Jiangsu GDK Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Jiangsu GDK Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu GDK Recent Developments
11.10 KM Biologics
11.10.1 KM Biologics Corporation Information
11.10.2 KM Biologics Overview
11.10.3 KM Biologics Injection Flu Shot Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 KM Biologics Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 KM Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Injection Flu Shot Industry Chain Analysis
12.2 Injection Flu Shot Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Injection Flu Shot Production Mode & Process
12.4 Injection Flu Shot Sales and Marketing
12.4.1 Injection Flu Shot Sales Channels
12.4.2 Injection Flu Shot Distributors
12.5 Injection Flu Shot Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Injection Flu Shot Industry Trends
13.2 Injection Flu Shot Market Drivers
13.3 Injection Flu Shot Market Challenges
13.4 Injection Flu Shot Market Restraints
14 Key Findings in The Global Injection Flu Shot Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Injection Flu Shot Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Injection Flu Shot Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Injection Flu Shot Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Injection Flu Shot Sales by Region (2017-2022) & (Units)
Table 7. Global Injection Flu Shot Sales Market Share by Region (2017-2022)
Table 8. Global Injection Flu Shot Sales by Region (2023-2028) & (Units)
Table 9. Global Injection Flu Shot Sales Market Share by Region (2023-2028)
Table 10. Global Injection Flu Shot Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Injection Flu Shot Revenue Market Share by Region (2017-2022)
Table 12. Global Injection Flu Shot Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Injection Flu Shot Revenue Market Share by Region (2023-2028)
Table 14. Global Injection Flu Shot Sales by Manufacturers (2017-2022) & (Units)
Table 15. Global Injection Flu Shot Sales Share by Manufacturers (2017-2022)
Table 16. Global Injection Flu Shot Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Injection Flu Shot Revenue Share by Manufacturers (2017-2022)
Table 18. Injection Flu Shot Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Injection Flu Shot Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Injection Flu Shot by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Flu Shot as of 2021)
Table 21. Injection Flu Shot Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Injection Flu Shot Product Offered
Table 23. Date of Manufacturers Enter into Injection Flu Shot Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Injection Flu Shot Sales by Type (2017-2022) & (Units)
Table 26. Global Injection Flu Shot Sales by Type (2023-2028) & (Units)
Table 27. Global Injection Flu Shot Sales Share by Type (2017-2022)
Table 28. Global Injection Flu Shot Sales Share by Type (2023-2028)
Table 29. Global Injection Flu Shot Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Injection Flu Shot Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Injection Flu Shot Revenue Share by Type (2017-2022)
Table 32. Global Injection Flu Shot Revenue Share by Type (2023-2028)
Table 33. Injection Flu Shot Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Injection Flu Shot Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Injection Flu Shot Sales by Application (2017-2022) & (Units)
Table 36. Global Injection Flu Shot Sales by Application (2023-2028) & (Units)
Table 37. Global Injection Flu Shot Sales Share by Application (2017-2022)
Table 38. Global Injection Flu Shot Sales Share by Application (2023-2028)
Table 39. Global Injection Flu Shot Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Injection Flu Shot Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Injection Flu Shot Revenue Share by Application (2017-2022)
Table 42. Global Injection Flu Shot Revenue Share by Application (2023-2028)
Table 43. Injection Flu Shot Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Injection Flu Shot Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Injection Flu Shot Sales by Type (2017-2022) & (Units)
Table 46. North America Injection Flu Shot Sales by Type (2023-2028) & (Units)
Table 47. North America Injection Flu Shot Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Injection Flu Shot Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Injection Flu Shot Sales by Application (2017-2022) & (Units)
Table 50. North America Injection Flu Shot Sales by Application (2023-2028) & (Units)
Table 51. North America Injection Flu Shot Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Injection Flu Shot Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Injection Flu Shot Sales by Country (2017-2022) & (Units)
Table 54. North America Injection Flu Shot Sales by Country (2023-2028) & (Units)
Table 55. North America Injection Flu Shot Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Injection Flu Shot Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Injection Flu Shot Sales by Type (2017-2022) & (Units)
Table 58. Europe Injection Flu Shot Sales by Type (2023-2028) & (Units)
Table 59. Europe Injection Flu Shot Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Injection Flu Shot Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Injection Flu Shot Sales by Application (2017-2022) & (Units)
Table 62. Europe Injection Flu Shot Sales by Application (2023-2028) & (Units)
Table 63. Europe Injection Flu Shot Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Injection Flu Shot Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Injection Flu Shot Sales by Country (2017-2022) & (Units)
Table 66. Europe Injection Flu Shot Sales by Country (2023-2028) & (Units)
Table 67. Europe Injection Flu Shot Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Injection Flu Shot Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Injection Flu Shot Sales by Type (2017-2022) & (Units)
Table 70. Asia Pacific Injection Flu Shot Sales by Type (2023-2028) & (Units)
Table 71. Asia Pacific Injection Flu Shot Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Injection Flu Shot Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Injection Flu Shot Sales by Application (2017-2022) & (Units)
Table 74. Asia Pacific Injection Flu Shot Sales by Application (2023-2028) & (Units)
Table 75. Asia Pacific Injection Flu Shot Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Injection Flu Shot Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Injection Flu Shot Sales by Region (2017-2022) & (Units)
Table 78. Asia Pacific Injection Flu Shot Sales by Region (2023-2028) & (Units)
Table 79. Asia Pacific Injection Flu Shot Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Injection Flu Shot Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Injection Flu Shot Sales by Type (2017-2022) & (Units)
Table 82. Latin America Injection Flu Shot Sales by Type (2023-2028) & (Units)
Table 83. Latin America Injection Flu Shot Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Injection Flu Shot Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Injection Flu Shot Sales by Application (2017-2022) & (Units)
Table 86. Latin America Injection Flu Shot Sales by Application (2023-2028) & (Units)
Table 87. Latin America Injection Flu Shot Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Injection Flu Shot Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Injection Flu Shot Sales by Country (2017-2022) & (Units)
Table 90. Latin America Injection Flu Shot Sales by Country (2023-2028) & (Units)
Table 91. Latin America Injection Flu Shot Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Injection Flu Shot Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Injection Flu Shot Sales by Type (2017-2022) & (Units)
Table 94. Middle East and Africa Injection Flu Shot Sales by Type (2023-2028) & (Units)
Table 95. Middle East and Africa Injection Flu Shot Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Injection Flu Shot Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Injection Flu Shot Sales by Application (2017-2022) & (Units)
Table 98. Middle East and Africa Injection Flu Shot Sales by Application (2023-2028) & (Units)
Table 99. Middle East and Africa Injection Flu Shot Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Injection Flu Shot Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Injection Flu Shot Sales by Country (2017-2022) & (Units)
Table 102. Middle East and Africa Injection Flu Shot Sales by Country (2023-2028) & (Units)
Table 103. Middle East and Africa Injection Flu Shot Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Injection Flu Shot Revenue by Country (2023-2028) & (US$ Million)
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Sanofi Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Sanofi Recent Developments
Table 110. CSL Corporation Information
Table 111. CSL Description and Major Businesses
Table 112. CSL Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. CSL Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. CSL Recent Developments
Table 115. GSK Corporation Information
Table 116. GSK Description and Major Businesses
Table 117. GSK Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. GSK Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GSK Recent Developments
Table 120. Viatris Corporation Information
Table 121. Viatris Description and Major Businesses
Table 122. Viatris Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Viatris Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Viatris Recent Developments
Table 125. AstraZeneca Corporation Information
Table 126. AstraZeneca Description and Major Businesses
Table 127. AstraZeneca Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. AstraZeneca Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. AstraZeneca Recent Developments
Table 130. Hualan Bio Corporation Information
Table 131. Hualan Bio Description and Major Businesses
Table 132. Hualan Bio Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Hualan Bio Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Hualan Bio Recent Developments
Table 135. Changchun Institute of Biological Corporation Information
Table 136. Changchun Institute of Biological Description and Major Businesses
Table 137. Changchun Institute of Biological Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Changchun Institute of Biological Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Changchun Institute of Biological Recent Developments
Table 140. Sinovac Corporation Information
Table 141. Sinovac Description and Major Businesses
Table 142. Sinovac Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Sinovac Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sinovac Recent Developments
Table 145. Jiangsu GDK Corporation Information
Table 146. Jiangsu GDK Description and Major Businesses
Table 147. Jiangsu GDK Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Jiangsu GDK Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Jiangsu GDK Recent Developments
Table 150. KM Biologics Corporation Information
Table 151. KM Biologics Description and Major Businesses
Table 152. KM Biologics Injection Flu Shot Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. KM Biologics Injection Flu Shot Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. KM Biologics Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Injection Flu Shot Distributors List
Table 158. Injection Flu Shot Customers List
Table 159. Injection Flu Shot Market Trends
Table 160. Injection Flu Shot Market Drivers
Table 161. Injection Flu Shot Market Challenges
Table 162. Injection Flu Shot Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Injection Flu Shot Product Picture
Figure 3. Global Injection Flu Shot Market Share by Type in 2021 & 2028
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Injection Flu Shot Market Share by Application in 2021 & 2028
Figure 6. 6 Months to 3 Years
Figure 7. > 3 Years
Figure 8. Injection Flu Shot Report Years Considered
Figure 9. Global Injection Flu Shot Sales 2017-2028 (Units)
Figure 10. Global Injection Flu Shot Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Injection Flu Shot Revenue 2017-2028 (US$ Million)
Figure 12. Global Injection Flu Shot Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Injection Flu Shot Sales Market Share by Region (2017-2022)
Figure 14. Global Injection Flu Shot Sales Market Share by Region (2023-2028)
Figure 15. North America Injection Flu Shot Sales YoY (2017-2028) & (Units)
Figure 16. North America Injection Flu Shot Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Injection Flu Shot Sales YoY (2017-2028) & (Units)
Figure 18. Europe Injection Flu Shot Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Injection Flu Shot Sales YoY (2017-2028) & (Units)
Figure 20. Asia-Pacific Injection Flu Shot Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Injection Flu Shot Sales YoY (2017-2028) & (Units)
Figure 22. Latin America Injection Flu Shot Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Injection Flu Shot Sales YoY (2017-2028) & (Units)
Figure 24. Middle East & Africa Injection Flu Shot Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Injection Flu Shot Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Injection Flu Shot in the World: Market Share by Injection Flu Shot Revenue in 2021
Figure 27. Global Injection Flu Shot Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Injection Flu Shot Sales Market Share by Type (2017-2028)
Figure 29. Global Injection Flu Shot Revenue Market Share by Type (2017-2028)
Figure 30. Global Injection Flu Shot Sales Market Share by Application (2017-2028)
Figure 31. Global Injection Flu Shot Revenue Market Share by Application (2017-2028)
Figure 32. North America Injection Flu Shot Sales Market Share by Type (2017-2028)
Figure 33. North America Injection Flu Shot Revenue Market Share by Type (2017-2028)
Figure 34. North America Injection Flu Shot Sales Market Share by Application (2017-2028)
Figure 35. North America Injection Flu Shot Revenue Market Share by Application (2017-2028)
Figure 36. North America Injection Flu Shot Sales Share by Country (2017-2028)
Figure 37. North America Injection Flu Shot Revenue Share by Country (2017-2028)
Figure 38. United States Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Injection Flu Shot Sales Market Share by Type (2017-2028)
Figure 41. Europe Injection Flu Shot Revenue Market Share by Type (2017-2028)
Figure 42. Europe Injection Flu Shot Sales Market Share by Application (2017-2028)
Figure 43. Europe Injection Flu Shot Revenue Market Share by Application (2017-2028)
Figure 44. Europe Injection Flu Shot Sales Share by Country (2017-2028)
Figure 45. Europe Injection Flu Shot Revenue Share by Country (2017-2028)
Figure 46. Germany Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 47. France Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Injection Flu Shot Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Injection Flu Shot Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Injection Flu Shot Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Injection Flu Shot Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Injection Flu Shot Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Injection Flu Shot Revenue Share by Region (2017-2028)
Figure 57. China Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 60. India Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Injection Flu Shot Sales Market Share by Type (2017-2028)
Figure 67. Latin America Injection Flu Shot Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Injection Flu Shot Sales Market Share by Application (2017-2028)
Figure 69. Latin America Injection Flu Shot Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Injection Flu Shot Sales Share by Country (2017-2028)
Figure 71. Latin America Injection Flu Shot Revenue Share by Country (2017-2028)
Figure 72. Mexico Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 75. Colombia Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Injection Flu Shot Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Injection Flu Shot Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Injection Flu Shot Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Injection Flu Shot Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Injection Flu Shot Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Injection Flu Shot Revenue Share by Country (2017-2028)
Figure 82. Turkey Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Injection Flu Shot Revenue (2017-2028) & (US$ Million)
Figure 85. Injection Flu Shot Value Chain
Figure 86. Injection Flu Shot Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

以下、関連資料のご紹介

グセルクマブ注射のグローバル市場インサイト・予測（～2028年）

Global Guselkumab Injection Market Insights, Forecast to 2028
QY2207E10366 2022年7月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のグセルクマブ注射の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグセルクマブ注射の世...

ダラツムマブ注射のグローバル市場インサイト・予測（～2028年）

Global Daratumumab Injection Market Insights, Forecast to 2028
QY2207C3483 2022年7月11日 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のダラツムマブ注射の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にダラツムマブ注射の世...

注射ペプチド薬のグローバル市場インサイト・予測（～2028年）

Global Injection Peptide Drug Market Insights, Forecast to 2028
QY2207E10389 2022年7月 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の注射ペプチド薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に注射ペプチド薬の世界市...

注入用ヒアルロン酸のグローバル市場インサイト・予測（～2028年）

Global Injection Grade Hyaluronic Acid Market Insights, Forecast to 2028
QY2207E10387 2022年7月 92Pages
新型コロナウイルス感染症のパンデミックにより、世界の注入用ヒアルロン酸の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に注入用ヒアルロン酸...

インフルエンザワクチン注射のグローバル市場インサイト・予測（～2028年）

Global Injection Influenza Vaccine Market Insights, Forecast to 2028
QY2207E10388 2022年7月 108Pages
新型コロナウイルス感染症のパンデミックにより、世界のインフルエンザワクチン注射の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインフルエ...

インフルエンザワクチン注射のグローバル市場インサイト・予測（～2028年） Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
ヒト注射インフルエンザワクチンのグローバル市場インサイト・予測（～2028年） Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
世界のインフルエンザ用ワクチン市場予測（～2028年）：三価インフルエンザ用ワクチン、四価インフルエンザ用ワクチン The Vaccine for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
世界の犬用インフルエンザワクチン市場予測（～2028年）：液体、粉体 The Canine Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
世界の馬インフルエンザワクチン市場予測（～2028年）：液体、粉末 The Equine Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…